The AACR-Novocure Cancer Research Grants represent a joint effort to promote and support independent investigators who are currently conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage independent investigators to enter the TTFields research field. The Inovitro® system (which will be provided by Novocure, if needed), must be included in the experimental design. These grants are intended to provide a deeper understanding of the mechanisms of action of this novel anti-cancer treatment modality and to accelerate the development of new treatment strategies to advance therapeutic options for cancer.
Each grant provides $350,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators*, postdoctoral or clinical research fellows, graduate students and/or research assistants; research/laboratory supplies; equipment; travel; publication charges for manuscripts that pertain directly to the funded project; other research expenses; and indirect costs. (*Note that inter-laboratory collaboration is encouraged, particularly for applicants new to TTFields research.)